Cargando…

A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis

BACKGROUND: Systemic sclerosis (SSc) is a multi-organ autoimmune disease characterized by skin fibrosis. Internal organ involvement is heterogeneous. It is unknown whether disease mechanisms are common across all involved affected tissues or if each manifestation has a distinct underlying pathology....

Descripción completa

Detalles Bibliográficos
Autores principales:	Taroni, Jaclyn N., Greene, Casey S., Martyanov, Viktor, Wood, Tammara A., Christmann, Romy B., Farber, Harrison W., Lafyatis, Robert A., Denton, Christopher P., Hinchcliff, Monique E., Pioli, Patricia A., Mahoney, J. Matthew, Whitfield, Michael L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363043/ https://www.ncbi.nlm.nih.gov/pubmed/28330499 http://dx.doi.org/10.1186/s13073-017-0417-1

Ejemplares similares

Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms
por: Mahoney, J. Matthew, et al.
Publicado: (2015)

Molecular Signatures in Skin Associated with Clinical Improvement During Mycophenolate Treatment in Systemic Sclerosis
por: Hinchcliff, Monique, et al.
Publicado: (2013)

Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
por: Taroni, Jaclyn N., et al.
Publicado: (2015)

Regulator combinations identify systemic sclerosis patients with more severe disease
por: Wang, Yue, et al.
Publicado: (2020)

The cytokine language of monocytes and macrophages in systemic sclerosis
por: Christmann, Romy B, et al.
Publicado: (2010)

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature
por: Derrett-Smith, Emma C., et al.
Publicado: (2017)

Experimentally-Derived Fibroblast Gene Signatures Identify Molecular Pathways Associated with Distinct Subsets of Systemic Sclerosis Patients in Three Independent Cohorts
por: Johnson, Michael E., et al.
Publicado: (2015)

Identification of cell cycle–regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors
por: Grant, Gavin D., et al.
Publicado: (2013)

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
por: Gordon, Jessica K., et al.
Publicado: (2015)

High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis
por: Arron, Sarah T., et al.
Publicado: (2014)

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis
por: Spiera, Robert, et al.
Publicado: (2020)

Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
por: Chakravarty, Eliza F., et al.
Publicado: (2015)

Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury
por: Pendergrass, Sarah A., et al.
Publicado: (2010)

Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin
por: Johnson, Michael E., et al.
Publicado: (2019)

Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies
por: Pendergrass, Sarah A., et al.
Publicado: (2012)

Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
por: Lakota, Katja, et al.
Publicado: (2012)

Fibrosis in systemic sclerosis: common and unique pathobiology
por: Bhattacharyya, Swati, et al.
Publicado: (2012)

miR-155 in the progression of lung fibrosis in systemic sclerosis
por: Christmann, Romy B., et al.
Publicado: (2016)

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis
por: Johnson, Michael E., et al.
Publicado: (2016)

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer
por: Ball, Michael S., et al.
Publicado: (2020)

Assessment of diffuse myocardial fibrosis in systemic sclerosis by cardiac magnetic resonance imaging
por: Lee, Daniel C, et al.
Publicado: (2013)

Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis
por: Stifano, Giuseppina, et al.
Publicado: (2014)

Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
por: Hinchcliff, Monique, et al.
Publicado: (2020)

Tenascin-C drives persistence of organ fibrosis
por: Bhattacharyya, Swati, et al.
Publicado: (2016)

Cross-platform normalization enables machine learning model training on microarray and RNA-seq data simultaneously
por: Foltz, Steven M., et al.
Publicado: (2023)

Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2022)

The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients
por: Lenna, Stefania, et al.
Publicado: (2015)

Machine-learning classification identifies patients with early systemic sclerosis as abatacept responders via CD28 pathway modulation
por: Mehta, Bhaven K., et al.
Publicado: (2022)

Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
por: Lafyatis, R
Publicado: (2010)

Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1
por: BUJOR, ANDREEA M., et al.
Publicado: (2012)

Measurement of extracellular volume fraction by cardiac magnetic resonance imaging detects diffuse myocardial fibrosis in systemic sclerosis
por: Lee, Daniel C, et al.
Publicado: (2012)

Macrophages as determinants and regulators of fibrosis in systemic sclerosis
por: Al-Adwi, Yehya, et al.
Publicado: (2022)

Live-cell monitoring of periodic gene expression in synchronous human cells identifies Forkhead genes involved in cell cycle control
por: Grant, Gavin D., et al.
Publicado: (2012)

Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon
por: Teaw, Shannon, et al.
Publicado: (2023)

New Insights into the Mechanisms of Innate Immune Receptor Signalling in Fibrosis
por: Lafyatis, Robert, et al.
Publicado: (2012)

High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
por: Correia, Chase, et al.
Publicado: (2020)

p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis
por: Ghosh, Asish K, et al.
Publicado: (2013)

Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
por: Valenzi, Eleanor, et al.
Publicado: (2021)

Ten simple rules for large-scale data processing
por: Fungtammasan, Arkarachai, et al.
Publicado: (2022)

Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis
por: Lakota, Katja, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oe91bg53qi1rnh5bq35uqu59je